posted June 24, 2022 07:10 pm by armedescapade
(6)
Okee DoKeee, the news is out. Now what?
rate and reply
posted June 24, 2022 01:16 pm by Noteable
(794)
https://twitter.com/prECOGonc
rate and reply
posted June 24, 2022 11:16 am by Spdstr
(5)
The tweet link didn't included, here is the text PrECOG
...read more
posted June 24, 2022 10:39 am by Noteable
(794)
The tweet appearing in the previous post was made by Dr. Bryan Choi, a Boston/Harvard neurologist and neuroscientist affiliated with the Massachusettes General Hospital in Boston. The Mayo Clinic
...read more
posted June 24, 2022 10:19 am by Noteable
(794)
June 24, 2022 - The pharmaceutical and life sciences industry is poised for a “flurry of deals” in the second half, according to PwC. In a new report covering the first half of
...read more
posted June 23, 2022 10:49 pm by armedescapade
(6)
Are you my accountant now? What else do I have? Tell us. and what did you do to S er N err L aka NOTable? He run my inventory and accounts like a well oiled AI. I will miss him. Nuts
...read more
posted June 23, 2022 05:33 pm by Noteable
(794)
June 2022 - A patent cliff is looming once again for the biopharma industry, putting some $236 billion in pharmaceutical sales at risk between now and 2030. Take-aways: Companies won’t
...read more
posted June 23, 2022 05:25 pm by cardu
(38)
You must have a depressing life being so negative.
rate and reply
posted June 23, 2022 03:02 pm by armedescapade
(6)
Oh My Goodness, wagon full of fools. Going for a treatment, eh? Did everybody get their pain meds? The lube? The feathers? Almost forgot, the whips, The crocodile jaw, your favorite. Oh, Nellie!!!!!
rate and reply
posted June 23, 2022 12:35 pm by cardu
(38)
They'll be buying big time when the news comes out, and it will!
rate and reply
posted June 23, 2022 12:32 pm by Lesalpes29
(891)
Now Mr. Parsons has 45k options at 1.14.
rate and reply
posted June 23, 2022 10:55 am by inthno
(45)
it's not that no one is selling , it's more no one is buying is where we stand right now....
rate and reply
posted June 23, 2022 10:03 am by cardu
(38)
Add to that- the volume is pathetic. No one is selling.
rate and reply
posted June 23, 2022 07:38 am by Lesalpes29
(891)
New director, insiders buying, insiders loaded with cheap options. The only missing piece is a significant NR. Fingers crossed for the coming weeks. GL
rate and reply
posted June 21, 2022 04:15 pm by Noteable
(794)
IBB: M&As Are Back Jun. 21, 2022 4:56 AM ETiShares Nasdaq Biotechnology ETF (IBB)CRSP, PFE, VRTX1 Like Summary Biotech stocks have had a terrible year so far
...read more
posted June 19, 2022 09:22 am by Noteable
(794)
According to the 32nd edition of the Beyond Borders report produced by Ernst & Young LLP (EY US) contributor Arda Ural, PhD, EY Americas industry markets leader, health sciences and
...read more
posted June 19, 2022 03:38 am by askretka
(248)
Recent Dr. VILE tweet. " Several cancers share antigens that could be targets across treatments. Also run the risk of reacting with normal tissues." -----------------------------------------
...read more
posted June 18, 2022 03:22 pm by Noteable
(794)
Merck had formed a partnership with Seagen through an exclusive license to commercialize Seagen's Tukysa in several regions outside the U.S. and Canada. Seagen, formerly Seattle Genetics, received
...read more